Amanote Research

Amanote Research

    RegisterSign In

Topical Nepafenac in the Treatment of Diabetic Macular Edema

Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s3965
Full Text
Open PDF
Abstract

Available in full text

Categories
Ophthalmology
Date

October 1, 2008

Authors
David Callanan
Publisher

Informa UK Limited


Related search

Topical Mecamylamine for Diabetic Macular Edema

American Journal of Ophthalmology
Ophthalmology
2010English

Treatment of Cystoid Macular Edema With the New-Generation NSAID Nepafenac 0.1%

Clinical Ophthalmology
Ophthalmology
2009English

The Evolving Treatment Options for Diabetic Macular Edema

International Journal of Inflammation
AllergyImmunology
2013English

New Strategies for Treatment of Diabetic Macular Edema

Journal of Ophthalmology
Ophthalmology
2018English

Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

Global Journal of Pharmacy & Pharmaceutical Sciences
2018English

Vitreoschisis in Diabetic Macular Edema

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2011English

Diabetic Macular Edema : Overview

Indian Journal of Clinical and Experimental Ophthalmology
2018English

Comparative Study of Intravitreal Ranibizumab With and Without Nepafenac Eye Drops for Center Involving Diabetic Macular Edema

Journal of Medical Science And clinical Research
2015English

Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema

JAMA Ophthalmology
Ophthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy